The inaugural ASCO Oncology Practice Conference, an educational meeting focused on the business of cancer care, will feature sessions led by renowned faculty addressing the regulatory, administrative, and legal challenges faced by oncology practices in the current dynamic environment. All professionals involved in the business and management of oncology practices should plan to attend this one-day event. Held one day prior to the successful ASCO Quality Care Symposium, attendees can maximize their time away from the office by attending both meetings.
New for 2017, attendees need their username and password to access the CE Portal. If you do not know your username or password, you may use your email address to retrieve them. If you do not know the email address associated with your account, please contact
- Onsite: ASCO staff at the Tech Help Desk in the Posters, Exhibits, and Food Service Room or at the Registration and Customer Service Desk.
- Off-site: ASCO Customer Service from 8:30 AM - 5:00 PM (ET) at email@example.com, 888-282-2552 or 703-299-0158.
Accreditation and Designation Statement
In support of improving patient care, the American Society of Clinical Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
AMA Credit Designation Statement – Physicians
The American Society of Clinical Oncology designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other attendees may request a Certificate of Participation after submitting their session participation. Please note that all final decisions regarding certificate acceptance toward any licensure requirements will be made by the licensing organization to which the certificate is submitted.
Educational Needs Statement
The inaugural ASCO Oncology Practice Conference: The Business of Cancer Care is a one-day forum that allows administrators and healthcare professionals to participate in a stimulating dialogue and to receive crucial updates on the business aspect of cancer care. With ever-changing regulatory legislations and standards, healthcare professionals and administrators will benefit from these updates so that they can improve how they provide patient care and with optimal treatment.
This Conference is designed for professionals involved in the business and management of oncology practices, including practice leadership, practice physician managing partners, practice administrators/managers, physicians in practice, ASCO PracticeNET participants, ASCO State/Regional Affiliate members, medical directors, oncology program directors, oncology service line administrators, nurse managers/clinical managers, consultants, and industry stakeholders.
Learning Objectives and Competencies
Upon participation in this activity, attendees will be able to:
- Identify the immediate steps needed for practices to effectively respond to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) requirements.
- List strategies to address practice challenges brought about by changes in the administrative, regulatory, and legal environments to care for patients with cancer.
- Compare and contrast the financial and administrative implications of participation in MACRA using the Merit-Based Incentive Payment System (MIPS) versus Alternative Payment Models (APMs).
- Evaluate the impact of various medical delivery methods and apply the lessons learned to optimize the sustainability of practice and be able to achieve the practice’s mission.
- Describe implications of consolidation for practices, payers, industry, and patients and the select strategies to effectively address the business challenges in cancer care and treatment.
|Institute of Medicine (IOM) Competencies||Accreditation Council for Graduate Medical Education (ACGME) Core Competencies|
Disclaimer and Unlabeled Usage Statement
The information presented is that of the contributing faculty and presenters and does not necessarily represent the views of the Symposium and/or any named company or organization providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty or presenters. Therefore, before presenting any medication, please review the complete prescribing information including indications, contraindications, warnings, precautions, and adverse effects.